PharmEasy
Signal active
Investment Firm
Overview
PharmEasy is a health tech startup offering services such as teleconsultation, medicine deliveries, and diagnostic test sample collections.
It also operates an online pharmacy that helps patients connect with local pharmacy stores and diagnostic centers in order to fulfill their extensive medical needs. The startup company is funded and backed by Caisse de Dépôt et Placement du Québec (CDPQ), Ascent Health, Bessemer Venture Partners, Orios Venture Partners, Eight Roads Ventures, InnoVen Capital, and Temasek Holdings.
PharmEasy was founded in 2015 by Dharmil Sheth, Mikhil Innani, and Dhaval Shah as a subsidiary of Ascent Health.
Highlights
Founded
2015
Industry
E-Commerce
Employees
5001-10000
Investment
1
Lead Investment
0
Exits
undefined
Stages
Early Stage Venture
Investor Type
N/A
Location
India, Asia
Contact Information
Social
Profile Resume
PharmEasy, established in 2015 and headquartered in India, Asia., specializes in Early Stage Venture investments across Financial Services, Venture Capital, Angel Investment, Finance, Banking, Health Care. Their recent investments include Orios Venture Partners, Merisis Advisors, W Health Ventures. The highest investment round they participated in was $314.3M. Among their most notable exits are Orios Venture Partners and Merisis Advisors. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
N/A
investments
1
Diversity investments
0
Lead investments
0
Number of exits
undefined
Investments
1
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Jul 07, 2021 | - | - | 5.6M |
Exits
0
Funding Timeline
Funding rounds
1
Investors
49
Funds
0
Funding Rounds
1
PharmEasy has raised 1 rounds. Their latest funding was raised on Jul 07, 2021 from a Series B - BeatO round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Jul 07, 2021 | Series B - BeatO | - | 5.6M | - |
Investors
62
PharmEasy is funded by 62 investor(s). Goldman Sachs and Temasek Holdings Kantor are the most recent investors.
| Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|
360 ONE Asset | No | Venture Round - PharmEasy | 216.2M |
Caisse de Depot et Placement du Quebec | No | Venture Round - PharmEasy | 216.2M |
Temasek Holdings | No | Venture Round - PharmEasy | 216.2M |
Goldman Sachs | No | Venture Round - PharmEasy | 216.2M |
Temasek HoldingsFund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.